Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced that it has expanded.
Can-Fite BioPharma Ltd.: Can-Fite Expands the Out-Licensing Deal with Ewopharma to Include the Pancreatic Cancer Indication finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
By Rob Curran Shares of Kura Oncology were higher after the cancer-drug developer reported promising results from an early-stage trial of a leukemia drug..
Can-Fite BioPharma (CANF) Reports Publication Showing Positive Data from COMFORT-1 Phase III Psoriasis Study streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
StockNews.com Begins Coverage on Can-Fite BioPharma (NYSE:CANF) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.